March 14, 2025 — China’s recent breakthroughs in AI have captured global attention, but a quieter revolution is unfolding in biotech. Once known primarily for generics and contract manufacturing, China’s pharmaceutical companies are now emerging as global leaders in fast, cost-efficient drug discovery. In this episode of the Center for China Analysis (CCA) webinar series, China’s DeepSeek Moment, Lizzi C. Lee, fellow on Chinese Economy at Center for China Analysis, speaks with Gary Rieschel, founding managing partner of Qiming Venture Partners, to explore how China has transformed from a fast follower into a serious innovator. Introductory remarks by Jing Qian, co-founder and managing director of the Center for China Analysis. (35 min, 15 sec.)

To learn more about the Cure4Cancer global movement, visit the website.